Evidence map›Paper›PMID 39130811›Full record

ArticleClinical case reports2024

A case of COVID-19-associated C-ANCA vasculitis, was successfully treated with rituximab therapy.

Michael Filoramo, Renish Contractor, Deepak Chandramohan, Prabhat Singh, Nihar Jena, Prathap Kumar Simhadri

Abstract readCase Reports
In one paragraph

Article in Clinical case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Michael FiloramoFSU College of Medicine Daytona Beach Florida USA.
Renish ContractorFSU College of Medicine Daytona Beach Florida USA.
Deepak ChandramohanUAB School of Medicine Birmingham Alabama USA.
Prabhat SinghChristus Spohn Hospital Corpus Christi Texas USA.
Nihar JenaWayne State University Detroit Michigan USA.
Prathap Kumar SimhadriFSU College of Medicine Daytona Beach Florida USA.ORCID https://orcid.org/0000-0002-3209-8466

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Both C-anti-neutrophil cytoplasmic antibody (ANCA) and P-ANCA vasculitis were reported to be associated with COVID-19 infection. The ideal management of COVID-19-associated ANCA vasculitis is unclear, as the experiences were limited to case reports. We presented a case of COVID-19-associated C-ANCA vasculitis, successfully treated with steroids and rituximab therapy without any significant adverse reactions.

Indexed as

ANCA‐vasculitisANCA vasculitis managementCOVID‐19 induced ANCA vasculitisCOVID‐19 infectioninfection associated vasculitis

Identifiers

PMID39130811
PMCPMC11316008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.